Mavyretz Approved for Acute Hepatitis C; ALD Deaths Double; Entyvio in Pregnancy

(MedPage Today) — The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first treatment for acute hepatitis C virus, AbbVie announced.
Compared with no treatment for chronic hepatitis…

Source link : https://www.medpagetoday.com/gastroenterology/generalgastroenterology/116048

Author :

Publish date : 2025-06-12 19:38:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Mavyretz Approved for Acute Hepatitis C; ALD Deaths Double; Entyvio in Pregnancy

Why John Stewart Bell has been haunting quantum mechanics for decades

Early FIT Linked to Reduced Colon Cancer Incidence, Mortality

Related Posts

Repairing the Aging Blood-Brain Barrier: Real Possibilities

Wives of Farm Pesticide Applicators at Risk for Incident RA

Walking and Diet Boost Cognition in At-Risk Adults

Rust-based battery connects to an electricity grid for the first time

GLP-1 Users May Face Optic Nerve Damage Risk in First Year

Best Hospitals Ranked for Gastroenterology and GI Surgery

Repairing the Aging Blood-Brain Barrier: Real Possibilities

Wives of Farm Pesticide Applicators at Risk for Incident RA

Walking and Diet Boost Cognition in At-Risk Adults

Rust-based battery connects to an electricity grid for the first time

GLP-1 Users May Face Optic Nerve Damage Risk in First Year

Best Hospitals Ranked for Gastroenterology and GI Surgery

FDA Puts Alopecia Treatment on Fast Track

U.S. News Rates Johns Hopkins as Top Rheumatology Hospital

Categories

Archives